Nexalin Technology (NXL) Gross Margin (2021 - 2026)
Nexalin Technology's (NXL) quarterly Gross Margin came in at 87.85% in Q1 2026, up 2090.0% year-on-year from 4.01% in Q1 2025, and little changed quarter-over-quarter from 87.77% in Q4 2025.
Nexalin Technology (NXL) Gross Margin (2021 - 2026) Analysis & Trends
Nexalin Technology's Gross Margin history runs 6 years deep, the most recent figure standing at 87.85% for Q1 2026.
- On a quarterly basis, Gross Margin rose 2090.0% year-over-year to 87.85% in Q1 2026; TTM through Mar 2026 was 81.99%, a 1327.0% increase from a year earlier, with the FY2025 full-year figure at 79.65%, up 134.0% from the prior year.
- Gross Margin was little changed at 87.85% in Q1 2026 per NXL's latest filing, from 87.77% in the prior quarter.
- Across five years, Gross Margin topped out at 88.36% in Q1 2024 and bottomed at 64.77% in Q3 2024.
- The 5-year median for Gross Margin is 74.53% (2023), against an average of 76.43%.
- Across the five-year window, Gross Margin sank 2206 bps in 2022 and jumped 2090 bps in 2026, its largest moves.
- Year by year, Gross Margin stood at 82.13% in 2022, then retreated by 9 bps to 74.53% in 2023, then retreated by 3 bps to 72.42% in 2024, then advanced by 21 bps to 87.77% in 2025, then advanced by 0 bps to 87.85% in 2026.
- Per Business Quant, the three latest NXL Gross Margin figures stand at 87.85% (Q1 2026), 87.77% (Q4 2025), and 78.25% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nexalin Technology | 9.32 Mn | 6.61 Mn | 13,133.00 | 87.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87.85% |
| Dec 31, 2025 | 87.77% |
| Sep 30, 2025 | 78.25% |
| Jun 30, 2025 | 67.65% |
| Mar 31, 2025 | 66.94% |
| Dec 31, 2024 | 72.42% |
| Sep 30, 2024 | 64.77% |
| Jun 30, 2024 | 73.00% |
| Mar 31, 2024 | 88.36% |
| Dec 31, 2023 | 74.53% |
| Sep 30, 2023 | 83.52% |
| Jun 30, 2023 | 73.62% |
| Mar 31, 2023 | 76.73% |
| Dec 31, 2022 | 82.13% |
| Sep 30, 2022 | 65.65% |
| Jun 30, 2022 | 70.30% |
| Mar 31, 2022 | 85.77% |
| Dec 31, 2021 | 104.19% |
| Sep 30, 2021 | 83.37% |